← Back to guidelines
Psychiatry2 papers

Shigella boydii colitis

Last edited: 4/10/2026

Overview

Shigella boydii is a species of Gram-negative bacteria that is a cause of bacterial dysentery, commonly known as shigellosis. Shigellosis is characterized by inflammation of the intestinal lining, leading to symptoms such as diarrhea, fever, and abdominal cramps.

Diagnosis

  • Diagnosis is typically made based on clinical presentation and confirmed by stool culture 1.
  • Stool microscopy may reveal white blood cells and red blood cells 1.
  • Rapid antigen detection tests are available but may have lower sensitivity than culture 1.
  • Management

  • Treatment for shigellosis is primarily supportive, focusing on hydration and electrolyte balance 1.
  • Antibiotics are recommended for moderate to severe cases to reduce the duration of illness and transmission 1.
  • Commonly used antibiotics include fluoroquinolones (e.g., ciprofloxacin), azithromycin, and ceftriaxone 1.
  • Antimicrobial resistance is a significant concern, and susceptibility testing is crucial for guiding antibiotic choice 1.
  • Special Populations

  • In children, dehydration is a major concern, and oral rehydration therapy is the cornerstone of management 1.
  • Elderly individuals and those with compromised immune systems may be at higher risk for severe disease 1.
  • Key Recommendations

  • Fluid and electrolyte management is essential for all patients with shigellosis 1. (Evidence: Moderate)
  • Antibiotic therapy should be considered for moderate to severe shigellosis to shorten illness duration and reduce transmission 1. (Evidence: Moderate)
  • Empirical antibiotic choice should consider local resistance patterns, with fluoroquinolones, azithromycin, or ceftriaxone being common options 1. (Evidence: Moderate)
  • References

    1 Vindegaard N, Speyer H, Nordentoft M, Rasmussen S, Benros ME. Gut microbial changes of patients with psychotic and affective disorders: A systematic review. Schizophrenia research 2021. link

    Original source

    1. [1]
      Gut microbial changes of patients with psychotic and affective disorders: A systematic review.Vindegaard N, Speyer H, Nordentoft M, Rasmussen S, Benros ME Schizophrenia research (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG